Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  British medical journal

• Publication date

  1977-08-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.2.6084.419PMID 329943PMCID PMC1631214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Practolol in acute myocardial infarction.

  2009cited by this paper
• Effect of posterior hypothalamic stimulation on ventricular fibrillation threshold.

  1975cited by this paper
• Letter: Reduction of sudden Deaths after myocardial infarction.

  1974cited by this paper
• Protective effect of beta adrenoceptor blockade in experimental coronary occlusion in conscious dogs.

  1972cited by this paper
• Effect of propranolol on arrhythmias following coronary artery occlusion in dogs.

  1967cited by this paper
• Beta-adrenergic blockade in experimental myocardial infarction.

  1966cited by this paper

• Beta-blockers in patients without heart failure after myocardial infarction.

  2021cites this paper
• From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not Work

  2019cites this paper
• Is exercise-based cardiac rehabilitation effective? A systematic review and meta-analysis to re-examine the evidence

  2018cites this paper
• Does modern medicine increase life-expectancy: Quest for the Moon Rabbit?

  2016cites this paper
• Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease – should one consider disease location? Authors’ reply

  2016cites this paper
• When is Drug Therapy Warranted to Prevent Sudden Cardiac Death?

  2012cites this paper
• Снижение частоты сердечных сокращений как терапевтическая цель: фокус на первичную профилактику Heart rate reduction as a therapeutic goal: focus on primary prevention

  2012cites this paper
• Calcium Antagonists in Secondary Prevention after Myocardial Infarction

  2012cites this paper
• Rehabilitation after myocardial infarction trial (RAMIT): multi-centre randomised controlled trial of comprehensive cardiac rehabilitation in patients following acute myocardial infarction

  2011cites this paper
• The Problem of Subgroup Analyses: An Example from a Trial on Ruptured Intracranial Aneurysms

  2011cites this paper
• Established beta-adrenergic receptor blocking therapy and acute myocardial infarction. A clinical study of risks and benefits.

  2009cites this paper
• Meta-analysis in medical research: potentials and limitations.

  2008cites this paper
• Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease

  2006cites this paper
• Cardioprotective and antiarrhythmic effects ofβ-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia

  2005cites this paper
• Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.

  2005cites this paper
• Cardiovascular drug class specificity: beta-blockers.

  2004cites this paper
• Initiation and maintenance of beta-blockade with intravenous oxprenolol

  2004cites this paper
• Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease

  2004cites this paper
• Impact of age and sex on sudden cardiovascular death following myocardial infarction

  2002cites this paper
• Recommandations de la Société française de cardiologie concernant la prise en charge de l'infarctus du myocarde après la phase aiguë

  2001cites this paper
• Effect of beta blockade with and without sympathomimetic activity (ISA) on sympathovagal balance and baroreflex sensitivity.

  1999cites this paper
• Secondary prevention of myocardial infarction: role of beta-adrenergic blockers and angiotensin-converting enzyme inhibitors.

  1999cites this paper
• Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction

  1997cites this paper
• Beyond hyperkalemia: beta-blocker-induced cardiac arrest for normothermic cardiac operations.

  1997cites this paper
• Management of Acute Myocardial Infarction in the Elderly

  1996cites this paper
• Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators.

  1995cites this paper
• Cost-effectiveness analysis in heart disease, Part III: Ischemia, congestive heart failure, and arrhythmias.

  1995cites this paper
• Management of acute myocardial infarction in the elderly.

  1995cites this paper
• Effects of beta blockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects.

  1993cites this paper
• Toward the quiescent coronary plaque.

  1993cites this paper
• A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.

  1993cites this paper
• Beneficial effect of long-term beta blockade after acute myocardial infarction in patients without anterograde flow in the infarct artery.

  1991cites this paper
• Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol.

  1990cites this paper
• Evaluating effects of treatment in subgroups of patients within a clinical trial: the case of non-Q-wave myocardial infarction and beta blockers.

  1990cites this paper
• Relevance of intrinsic sympathomimetic activity for beta blockers.

  1990cites this paper
• Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.

  1990cites this paper
• Beta-adrenergic blockade and calcium channel blockade in myocardial infarction.

  1989cites this paper
• Acute hemodynamic effects of pindolol and propranolol in patients with dilated cardiomyopathy: relevance of intrinsic sympathomimetic activity.

  1988cites this paper
• Secondary prevention after myocardial infarction: Effects of beta blocking agents and calcium antagonists

  1988cites this paper
• Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction.

  1988cites this paper
• ß-Blockade after Myocardial Infarction: Is Prolonged Treatment Feasible?

  1987cites this paper
• Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts.

  1987cites this paper
• Falsely favourable early prognosis for continuing smokers following recovery from acute myocardial infarction. Information from the multi‐centre practolol trial

  1987cites this paper
• Therapeutic trends in the management of patients with acute myocardial infarction (1975–1984): the worcester heart attack study

  1987cites this paper
• Beta-adrenergic receptor properties of canine myocardium: effects of chronic myocardial infarction.

  1986cites this paper
• The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmia.

  1986cites this paper
• The evaluation of trials of medical therapy

  1985cites this paper
• Use of beta-adrenergic blocking agents after myocardial infarction.

  1985cites this paper
• Enhancement of visit adherence in the national beta-blocker heart attack trial.

  1985cites this paper
• Value of programmed stimulation and exercise testing in predicting one-year mortality after acute myocardial infarction.

  1985cites this paper
• Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial.

  1984cites this paper
• A classification of antiarrhythmic actions reassessed after a decade of new drugs.

  1984cites this paper
• Effect of long-term prophylactic treatment on survival after myocardial infarction.

  1984cites this paper
• Therapeutic interventions in acute myocardial infarction. Survey of the ACCP Section on Clinical Cardiology.

  1984cites this paper
• Protection of ischemic myocardium during or after convalescence from acute myocardial infarction.

  1984cites this paper
• Beta-adrenergic blockade for survivors of acute myocardial infarction.

  1984cites this paper
• Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.

  1984cites this paper
• Disopyramide

  1984cites this paper
• Considerations in the Long‐Term Management of Survivors of Cardiac Arrest a

  1984cites this paper
• An Epidemiological Perspective of Sudden Death 26-Year Follow-Up in the Framingham Study

  1984cites this paper
• Beta blockers in ischemic heart disease.

  1983cites this paper
• Role of beta-adrenergic blockade in the therapy of patients with myocardial infarction.

  1983cites this paper
• Haemodynamic dose-response effects of i.v. penbutolol in angina pectoris.

  1983cites this paper
• Beta adrenoceptor antagonists after myocardial infarction--where are we now?

  1983cites this paper
• Prevention of heart disease with oxprenolol.

  1983cites this paper
• Beta-blockers and myocardial infarction: infarction and ischaemia in the practolol and propranolol trials.

  1983cites this paper
• Beta-adrenergic blocking drugs in the treatment of hypertension.

  1983cites this paper
• Contribution of thrombogenic factors to the pathogenesis of atherosclerosis.

  1983cites this paper
• Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue?

  1983cites this paper
• Chronic beta blockade therapy in patients after myocardial infarction.

  1983cites this paper
• Hypoxic cardiac hypertrophy is not inhibited by cardioselective or non‐selective beta‐adrenoceptor antagonists.

  1982cites this paper
• One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.

  1982cites this paper
• Secondary prevention after myocardial infarction: a review of long-term trials.

  1982cites this paper
• Ventricular Antiarrhythmic Effects of Beta‐Adrenergic Blocking Drugs: A Review of Mechanism and Clinical Studies

  1982cites this paper
• Now you see it, now you don't. Eccentricities and anomalies in the results of beta-blocking trials.

  1982cites this paper
• More on the timolol study.

  1982cites this paper
• Beta-blockade after myocardial infarction--a statistical view.

  1982cites this paper
• Exercise testing early after myocardial infarction. Risks and benefits.

  1982cites this paper
• BETA BLOCKING AGENTS: CURRENT STATUS IN THE PREVENTION OF SUDDEN CORONARY DEATH *

  1982cites this paper
• The effects of nadolol on various cardiac tissues in normoxia, and on atrial muscle in simulated ischaemia.

  1982cites this paper
• Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?

  1982cites this paper
• Prognostic Value of Exercise Testing, Coronary Angiography and Left Ventriculography 6–8 Weeks After Myocardial Infarction

  1982cites this paper
• A long-term prevention study with oxprenolol in coronary heart disease.

  1982cites this paper
• Clinical experience with beta adrenergic blocking agents in myocardial ischaemia: a dilemma and a challenge.

  1981cites this paper
• Prophylaxis of myocardial infarction.

  1981cites this paper
• Pharmacokinetics, Mechanisms of Action, Indications, and Adverse Effects of Timolol Maleate, A Nonselective Beta‐Adrenoreceptor Blocking Agent

  1981cites this paper
• Beta-adrenergic blockade after myocardial infarction.

  1981cites this paper
• Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man.

  1981cites this paper
• PATIENTS' NEEDS IN DRUG DEVELOPMENT AND REGULATION

  1981cites this paper
• Beta Blocker Heart Attack Trial: design features.

  1981cites this paper
• New perspectives in the pharmacologic therapy of cardiac arrhythmias.

  1980cites this paper
• Chronic ventricular arrhythmias: comparative drug effectiveness and toxicity.

  1980cites this paper
• Dietary prevention of ischaemic heart disease--a policy for the '80s.

  1980cites this paper
• Neural mechanisms in life-threatening arrhythmias.

  1980cites this paper
• Treatment of the patient after myocardial infarction. The last decade and the next.

  1980cites this paper
• International symposium on infarct size utrecht, holland— April 9–10, 1979 trends in infarct size reduction: From intention to intervention

  1979cites this paper
• Mexiletine: A Review of its Pharmacological Properties and Therapeutic Efficacy in Arrhythmias

  1979cites this paper
• The influence of combined treatment with propranolol and acetylsalicylic acid on platelet aggregation in coronary heart disease.

  1979cites this paper
• Principles of drug treatment for hypertension: indications for treatment and for selection of drugs.

  1979cites this paper
• Therapy with antiarrhythmic drugs.

  1978cites this paper